9690 Federal Register / Vol. 60, No. 34 / Tuesday, February 21, 1995 / Notices

hearing on this question must be

accompanied by a statement of the

reasons a written presentation would

not suffice in lieu of a hearing,

identifying specifically any questions of

fact that are in dispute, summarizing the

evidence that would be presented at a

hearing, and indicating how the party

commenting would be aggrieved by

approval of the proposal.

Comments regarding the application

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than March 7, 1995.

A. Federal Reserve Bank of Chicago

(James A. Bluemle, Vice President) 230

South LaSalle Street, Chicago, Illinois

60690:

1. Quad City Holdings, Inc.,

Bettendorf, Iowa; to engage de novo

through its subsidiary Quad City

Bancorp, Inc. Bettendorf, Iowa, in the

transfer of merchant credit card

operation, pursuant to § 225.25(b)(1) of

the Board’s Regulation Y.

Board of Governors of the Federal Reserve

System, February 14, 1995.

William W. Wiles,

Secretary of the Board.

[FR Doc. 95-4139 Filed 2-17-95; 8:45 am]

BILLING CODE 6210-01-F

Werner E. Schreiber Blind Trust, et al.;

Change in Bank Control Notices;

Acquisitions of Shares of Banks or

Bank Holding Companies

The notificants listed below have

applied under the Change in Bank

Control Act (12 U.S.C. 1817(j)) and §

225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire a bank or bank

holding company. The factors that are

considered in acting on the notices are

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

notices have been accepted for

processing, they will also be available

for inspection at the offices of the Board

of Governors. Interested persons may

express their views in writing to the

Reserve Bank indicated for that notice

or to the offices of the Board of

Governors. Comments must be received

not later than March 7, 1995.

A. Federal Reserve Bank of

Minneapolis (James M. Lyon, Vice

President) 250 Marquette Avenue,

Minneapolis, Minnesota 55480:

1. Werner E. Schreiber Blind Trust;

and Marlene I. Havens, Larry W. Jochim,

and Jerry J. James as co-trustee, all of

Whitefish, Montana; all to acquire 22.89

percent of the voting shares of Flathead

Holding Company, Bigfork, Montana,

and thereby indirectly acquire Flathead

Bank of Bigfork, Bigfork, Montana.

In addition Applicants also propose to

acquire a total of 73.95 percent of the

voting shares of Mountain Bank System,

Inc., Whitefish, Montana, and thereby

indirectly acquire Mountain Bank,

Whitefish, Montana, and Valley Bank of

Belgrade, Belgrade, Montana.

Board of Governors of the Federal Reserve

System, February 14, 1995.

William W. Wiles,

Secretary of the Board.

[FR Doc. 95-4138 Filed 2-17-95; 8:45 am]

BILLING CODE 6210-01-F

Wilson and Muir Bancorp, Inc., et al.;

Acquisitions of Companies Engaged in

Permissible Nonbanking Activities

The organizations listed in this notice

have applied under § 225.23(a)(2) or (f)

of the Board’s Regulation Y (12 CFR

225.23(a)(2) or (f)) for the Board’s

approval under section 4(c)(8) of the

Bank Holding Company Act (12 U.S.C.

1843(c)(8)) and § 225.21(a) of Regulation

Y (12 CFR 225.21(a)) to acquire or

control voting securities or assets of a

company engaged in a nonbanking

activity that is listed in § 225.25 of

Regulation Y as closely related to

banking and permissible for bank

holding companies. Unless otherwise

noted, such activities will be conducted

throughout the United States.

Each application is available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

application has been accepted for

processing, it will also be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether consummation of the

proposal can ‘‘reasonably be expected to

produce benefits to the public, such as

greater convenience, increased

competition, or gains in efficiency, that

outweigh possible adverse effects, such

as undue concentration of resources,

decreased or unfair competition,

conflicts of interests, or unsound

banking practices.’’ Any request for a

hearing on this question must be

accompanied by a statement of the

reasons a written presentation would

not suffice in lieu of a hearing,

identifying specifically any questions of

fact that are in dispute, summarizing the

evidence that would be presented at a

hearing, and indicating how the party

commenting would be aggrieved by

approval of the proposal.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated for the application or the

offices of the Board of Governors not

later than March 7, 1995.

A. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri 63166:

1. Wilson and Muir Bancorp, Inc.,

Bardstown, Kentucky; to acquire

Bankers Mortgage Corporation,

Louisville, Kentucky, and thereby

engage in the business of originating

and making loans secured by mortgages

on, or deeds of trust relating to, real

property, pursuant to § 225.25(b)(1) of

the Board’s Regulation Y.

B. Federal Reserve Bank of

Minneapolis (James M. Lyon, Vice

President) 250 Marquette Avenue,

Minneapolis, Minnesota 55480:

1. First Community Bancorp, Inc.,

Glasgow, Montana; to acquire First

National Agency, Hinsdale, Montana,

and thereby engage in operating a

general insurance agency in a town with

a population of less than 5,000,

pursuant to § 225.25(b)(8)(iii)(A) of the

Board’s Regulation Y.

Board of Governors of the Federal Reserve

System, February 14, 1995.

William W. Wiles,

Secretary of the Board.

[FR Doc. 95-4140 Filed 2-17-95; 8:45 am]

BILLING CODE 6210-01-F

HARRY S TRUMAN SCHOLARSHIP

FOUNDATION

Harry S Truman Scholarship 1995

Supplemental Competition

AGENCY: Harry S Truman Scholarship

Foundation.

ACTION: Notice of closing date for

Supplemental Nominations from

Eligible Institutions of Higher

Education.

SUMMARY: Notice is hereby given that,

pursuant to the authority contained in

the Harry S Truman Memorial

Scholarship Act, Public Law 93–642 (20

U.S.C. 2001), nominations are being

accepted from eligible institutions of

higher education for 1995 Truman

Scholarships. Procedures are prescribed

in 45 CFR 1801 (August 22, 1994; vol.

59, no. 161 sec. 13).

In order to be assured consideration,

all documentation in support of

nominations for the supplemental

competition must be received by the

Truman Scholarship Review Committee,

2255 N. Dubuque Road, P.O. Box 168,

Iowa City, IA 52243 no later than March

31, 1995, from participating two- and

four-year institutions.
Federal Register / Vol. 60, No. 34 / Tuesday, February 21, 1995 / Notices 9691

Dated: February 10, 1995.

Louis H. Blair,

Executive Secretary.

[FR Doc. 95–4091 Filed 2–17–95; 8:45 am]

BILLING CODE BOAC–95001–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 94N–0357]

Surveillance System for Antimicrobial

Resistance; Public Hearing; Reopening

of Comment Period

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice; reopening of comment

period.

SUMMARY: The Food and Drug

Administration (FDA) is reopening to

April 1, 1995, the comment period for

the notice of public hearing regarding

approaches to surveillance for the

development of bacterial resistance to

human and animal antimicrobial drugs,

which published in the Federal Register

of October 14, 1994 (59 FR 52168).

Interested persons were given until

February 1, 1995, to submit comments.

FDA is taking this action to provide

interested persons with an opportunity

to comment on submissions received

after the public hearing.

DATES: Submit written comments by

April 1, 1995.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, rm. 1–23, 12420

Parklawn Dr., Rockville, MD 20857.

Two copies of any comments are to be

submitted, except that individuals may

submit one copy. Comments are to be

identified with docket number found in

brackets in the heading of this

document. Received comments may be

seen in the Dockets Management Branch

between 9 a.m. and 4 p.m., Monday

through Friday. Transcripts of the

November 9 and 10, 1994, hearing are

available for review at the Dockets

Management Branch (address above).

FOR FURTHER INFORMATION CONTACT:

Ermona McGoodwin, Center for Drug

Evaluation and Research (HFD–9), Food

and Drug Administration, 5600 Fishers

Lane, Rockville, MD 20857, 301–443–

5455.

SUPPLEMENTARY INFORMATION: In the

Federal Register of October 14, 1994 (59

FR 52168), FDA announced that it

would be holding a public hearing

November 9 and 10, 1994, on

surveillance systems for antimicrobial

resistance. Interested persons were

given until February 1, 1995, to submit

comments. The purpose of the hearing

was to solicit information from, and the

views of, interested persons, including

scientists, professional groups, and

consumers, on the issues and concerns

relating to approaches for regulatory

purposes to surveillance for the

development of bacterial resistance to

antibacterial agents used in humans and

in animals. This hearing was held in

response to a recommendation for

improved surveillance for the

development of antimicrobial resistance

in both animals and humans as

discussed at the May 11 and 12, 1994,

joint meeting of FDA’s Anti-Infective

Drugs Advisory Committee and the

Veterinary Medicine Advisory

Committee (see the Federal Register of

April 15, 1994, (59 FR 18136 at 18137)).

FDA is actively seeking the views of

professional and consumer groups

regarding the implications of an animal

and human bacterial resistance

monitoring system for regulatory

purposes on their constituent

populations. To permit time for all

interested persons to comment on

submissions received after the public

hearing, the administrative record of the

hearing will remain open until April 1,

1995. Persons who wish to provide

additional materials for consideration

should file these materials with the

Dockets Management Branch (address

above) by April 1, 1995.

Dated: February 14, 1995.

William B. Schultz,

Deputy Commissioner for Policy.

[FR Doc. 95–4213 Filed 2–17–95; 8:45 am]

BILLING CODE 4160–01–F

National Institutes of Health

National Institute of Environmental

Health Sciences; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting:

Name of Committee: Environmental Health

Sciences Review Committee

Date: March 27–29, 1995.

Time: 8:30 a.m. to Adjournment.

Place: National Institute of Environmental

Health Sciences, Building 101 Conference

Room, South Campus, Research Triangle

Park, North Carolina.

Contact Person: Dr. Ethel Jackson,

Scientific Review Administrator, P.O. Box

12233, Research Triangle Park, NC 27709,

(919) 541–7826.

Purpose: To review and evaluate grant

applications.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.113, Biological Response to

Environmental Health Hazards; 93.114,

Applied Toxicological Research and Testing;

93.115, Biometry and Risk Estimation;

93.894, Research and Manpower

Development, National Institutes of Health.)

Dated: February 14, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–4114 Filed 2–17–95; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Initial

Review Group (IRG) meeting:

Name of IRG: Heart, Lung, and Blood

Program Project Review Committee.

Date: March 23–24, 1995.

Time: 8:00 a.m.

Place: Holiday Inn Chevy Chase, Chevy

Chase, Maryland.

Contact Person: Dr. Jeffrey Hurst, 5333

Westbard Avenue, Room 555, Bethesda,

Maryland 20892, (301) 594–7418.

Purpose/Agenda: To review and evaluate

grant applications.

The meeting will be closed in accordance

with the provisions set forth in sec.

552(b)(c)(4) and 552(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health.)

Dated: February 14, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–4112 Filed 2–17–95; 8:45 am]

BILLING CODE 4140–01–M